Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kindeva Drug Delivery is a leading global contract development and manufacturing organization (CDMO) specializing in complex drug-device combination products. Formed from the divestiture of 3M's drug delivery business, the company provides end-to-end capabilities for formulation, device development, and commercial manufacturing across multiple delivery routes, including pulmonary, nasal, transdermal, and intradermal. Kindeva is particularly recognized for its expertise in metered-dose inhalers (MDIs), transdermal patches, and microneedle-based delivery systems. The company partners with pharmaceutical and biotech firms to bring innovative therapies to market, leveraging a deep portfolio of intellectual property and state-of-the-art manufacturing facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delivery Systems.